nucmedbio (@nucmedbio) 's Twitter Profile
nucmedbio

@nucmedbio

Scientific journal on radiopharmaceutical sciences. Twitter account managed by the Editor in Chief, Bert Windhorst.

ID: 1381620131290361859

linkhttps://www.journals.elsevier.com/nuclear-medicine-and-biology calendar_today12-04-2021 14:48:15

44 Tweet

348 Followers

246 Following

nucmedbio (@nucmedbio) 's Twitter Profile Photo

New PET tracer for neurooncology with potential for boron neutron capture therapy. Just out in NMB #nucmedbio doi.org/10.1016/j.nucm…

nucmedbio (@nucmedbio) 's Twitter Profile Photo

On international women day 2022 we honor the contributions women have made to radiopharmaceutical sciences #WomensDay #nucmedbio. These are already out, several more to come! sciencedirect.com/journal/nuclea…

Tanja Sjöros (@tanjasjoros) 's Twitter Profile Photo

turkupet2022.fi is open for late breaking abstracts until 11 April! The Turku PET Symposium will be organised as an on-site event in June. Welcome to Turku! Turku PET Centre

Society of Radiopharmaceutical Sciences (SRS) (@socradiophsci) 's Twitter Profile Photo

TERACHEM 2022 is a conference uniquely focusing on all aspects of radiometals in medicine. The abstract submission system will close on April 22. Early registration ends June 30. To learn more about abstract submission & registration, browse: srsweb.org/terachem2022

TERACHEM 2022 is a conference uniquely focusing on all aspects of radiometals in medicine. The abstract submission system will close on April 22. Early registration ends June 30.

To learn more about abstract submission & registration, browse: srsweb.org/terachem2022
Society of Radiopharmaceutical Sciences (SRS) (@socradiophsci) 's Twitter Profile Photo

The deadline to submit an abstract to TERACHEM 2022 is Friday, April 22, 2022. srsweb.org/terachem2022ab… Nearly the entire program will be built on the strength of colleagues’ submission of their research. Abstracts will be blindly scored by a large list of qualified reviewers.

The deadline to submit an abstract to TERACHEM 2022 is Friday, April 22, 2022. srsweb.org/terachem2022ab…

Nearly the entire program will be built on the strength of colleagues’ submission of their research. Abstracts will be blindly scored by a large list of qualified reviewers.
ScottLab (@scott_labum) 's Twitter Profile Photo

Delighted to be working with Suzanne Lapi on a #Special_Issue of nucmedbio imagining what the future of our field looks like. The call for papers is open now -- please reach out to us with ideas and consider sending your work to the Official Journal of Society of Radiopharmaceutical Sciences (SRS)

Delighted to be working with <a href="/LapiSuzanne/">Suzanne Lapi</a> on a #Special_Issue of <a href="/nucmedbio/">nucmedbio</a> imagining what the future of our field looks like. The call for papers is open now -- please reach out to us with ideas and consider sending your work to the Official Journal of <a href="/SocRadiophSci/">Society of Radiopharmaceutical Sciences (SRS)</a>
Elsevier Radiology (@els_radiology) 's Twitter Profile Photo

Read the editor’s choice of the current issue of Nuclear Medicine and Biology: Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist spkl.io/60114ebd1 nucmedbio

Elsevier Radiology (@els_radiology) 's Twitter Profile Photo

Sergio Estrada et al. have won the 2022 Bill Eckelman Publication Award from Nuclear Medicine and Biology for their article Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase. Congrats! nucmedbio spkl.io/601645PXM

Sergio Estrada et al. have won the 2022 Bill Eckelman Publication Award from Nuclear Medicine and Biology for their article Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase. Congrats! <a href="/nucmedbio/">nucmedbio</a> spkl.io/601645PXM
Suzanne Lapi (@lapisuzanne) 's Twitter Profile Photo

Thank you Society of Radiopharmaceutical Sciences (SRS) for a fantastic #ISRS2023! For those of you looking to turn those amazing abstracts into papers, a reminder about the special issue of nucmedbio led by myself and ScottLab. journals.elsevier.com/nuclear-medici…

nucmedbio (@nucmedbio) 's Twitter Profile Photo

Last week at iSRS2023 Society of Radiopharmaceutical Sciences (SRS) I had the honor, together with SRS president Jason Lewis Jason Lewis Radiochem MSK, to award 4 young investigators for their excellent work! Congratulations to Mathilde Ligeour, James Omweri, Joni Sebastiano and Luke Wharton!! #nucmedbio

Last week at iSRS2023 <a href="/SocRadiophSci/">Society of Radiopharmaceutical Sciences (SRS)</a> I had the honor, together with SRS president Jason Lewis <a href="/LewisLabMSKCC/">Jason Lewis Radiochem MSK</a>, to award 4 young investigators for their excellent work!
Congratulations to Mathilde Ligeour, James Omweri, Joni Sebastiano and Luke Wharton!!
#nucmedbio
Werner Siemens Imaging Center (@wsic_tuebingen) 's Twitter Profile Photo

Recent paper on 'In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI' by J. Schwenck, D. Sonanini, Bernd Pichler, M. Kneilling, Prof. Dr. Christian la Fougère, and others, available here: thno.org/v13p2408

Recent paper on 'In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI' by J. Schwenck, D. Sonanini, <a href="/BerndJPichler/">Bernd Pichler</a>, M. Kneilling, <a href="/dr_clafougere/">Prof. Dr. Christian la Fougère</a>, and others, available here: thno.org/v13p2408
WMIS WMIC (@wmiswmic) 's Twitter Profile Photo

This week's MIB Paper of the Week focuses on receptor tyrosine kinase inhibitors, their role in tumorigenesis, and using HER3 PET imaging in gastric cancer models. Great work by Shadi Esfahani et al.! ow.ly/VE5p50OMjY2 Mass General Imaging

Elsevier Radiology (@els_radiology) 's Twitter Profile Photo

Read the editor’s choice of the current issue of nucmedbio - Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor spkl.io/601649MK2

nucmedbio (@nucmedbio) 's Twitter Profile Photo

New Impact Factor for NMB is 3.1. Again a significant increase. Thanks to all the high quality publications of radiopharmaceutical scientists!

nucmedbio (@nucmedbio) 's Twitter Profile Photo

Bill Eckelman Award 2023 I am happy to announce that the 2023 Bill Eckelman Award for best publication in NMB in 2023 goes to Maryam Oroujeni et al ‘Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3’ doi.org/10.1016/j.nucm…